Enhanced hematopoietic protection from radiation by the combination of genistein and captopril

International Immunopharmacology

Volumn 15, Issue 2, 2013, Pages 348-356

  Day, R M ^a   Davis, T A ^b   Barshishat Kupper, M ^a   McCart, E A ^a   Tipton, A J ^a   Landauer, M R ^c  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b NAVAL MEDICAL RESEARCH CENTER   (United States)

^c ARMED FORCES RADIOBIOLOGY RESEARCH INSTITUTE   (United States)

Author keywords

Captopril; Erythropoietin; Genistein; Hematopoietic cell recovery; Micronuclei; Radiation protection

Indexed keywords

CAPTOPRIL; COBALT 60; GENISTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CELL; CELL SURVIVAL; ERYTHROCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; RADIATION PROTECTION; STEM CELL; WHOLE BODY RADIATION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CAPTOPRIL; CELL SURVIVAL; CELLS, CULTURED; DRUG THERAPY, COMBINATION; ERYTHROCYTES; ERYTHROPOIETIN; FEMALE; GENISTEIN; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; MICE; MICE, INBRED C57BL; RADIATION INJURIES, EXPERIMENTAL; RADIATION-PROTECTIVE AGENTS; WHOLE-BODY IRRADIATION;

EID: 84873021436     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2012.12.029     Document Type: Article

References (44)

1. B. Movsas, B. Vikram, M. Hauer-Jensen, J.E. Moulder, E. Basch, and S.L. Brown Decreasing the adverse effects of cancer therapy: National Cancer Institute guidance for the clinical development of radiation injury mitigators Clin Cancer Res 17 2011 222 228
2. H.B. Stone, J.E. Moulder, C.N. Coleman, K.K. Ang, M.S. Anscher, and M.H. Barcellos-Hoff Models for evaluating agents intended for the prophylaxis, mitigation and treatment of radiation injuries. Report of an NCI Workshop, December 3-4, 2003 Radiat Res 162 2004 711 728
3. J. Buntzel, M. Glatzel, R. Mucke, O. Micke, and F. Bruns Influence of amifostine on late radiation-toxicity in head and neck cancer - a follow-up study Anticancer Res 27 2007 1953 1956
4. J.F. Weiss, and M.R. Landauer History and development of radiation-protective agents Int J Radiat Biol 85 2009 539 573
5. D. Rades, F. Fehlauer, A. Bajrovic, B. Mahlmann, E. Richter, and W. Alberti Serious adverse effects of amifostine during radiotherapy in head and neck cancer patients Radiother Oncol 70 2004 261 264
6. J. Newmark Therapy for nerve agent poisoning Arch Neurol 61 2004 649 652
7. M.R. Landauer, V. Srinivasan, and T.M. Seed Genistein treatment protects mice from ionizing radiation injury J Appl Toxicol 23 2003 379 385
8. T.A. Davis, M.R. Landauer, S.R. Mog, M. Barshishat-Kupper, S.R. Zins, and M.F. Amare Timing of captopril administration determines radiation protection or radiation sensitization in a murine model of total body irradiation Exp Hematol 38 2010 270 281
9. I. Kruk, H.Y. Aboul-Enein, T. Michalska, K. Lichszteld, and A. Kladna Scavenging of reactive oxygen species by the plant phenols genistein and oleuropein Luminescence 20 2005 81 89
10. T. Valachovicova, V. Slivova, and D. Sliva Cellular and physiological effects of soy flavonoids Mini Rev Med Chem 4 2004 881 887
11. H. Hong, M.R. Landauer, M.A. Foriska, and G.D. Ledney Antibacterial activity of the soy isoflavone genistein J Basic Microbiol 46 2006 329 335
12. M. Verdrengh, I.M. Jonsson, R. Holmdahl, and A. Tarkowski Genistein as an anti-inflammatory agent Inflamm Res 52 2003 341 346
13. T. Akiyama, J. Ishida, S. Nakagawa, H. Ogawara, S. Watanabe, and N. Itoh Genistein, a specific inhibitor of tyrosine-specific protein kinases J Biol Chem 262 1987 5592 5595
14. N. Tacyildiz, D. Ozyoruk, G. Yavuz, E. Unal, H. Dincaslan, and F. Dogu Soy isoflavones ameliorate the adverse effects of chemotherapy in children Nutr Cancer 62 2010 1001 1005
15. I.U. Ahmad, J.D. Forman, F.H. Sarkar, G.G. Hillman, E. Heath, and U. Vaishampayan Soy isoflavones in conjunction with radiation therapy in patients with prostate cancer Nutr Cancer 62 2010 996 1000
16. R. Day, M. Barshishat-Kupper, S.R. Mog, E.A. McCart, P.G. Prasanna, and T.A. Davis Genistein protects against biomarkers of delayed lung sequelae in mice surviving high dose total body irradiation J Radiat Res 49 2008 361 372
17. T.A. Davis, T.K. Clarke, S.R. Mog, and M.R. Landauer Subcutaneous administration of genistein prior to lethal irradiation supports multilineage, hematopoietic progenitor cell recovery and survival Int J Radiat Biol 83 2007 141 151
18. T.A. Davis, O. Mungunsukh, S. Zins, R.M. Day, and M.R. Landauer Genistein induces radioprotection by hematopoietic stem cell quiescence Int J Radiat Biol 84 2008 713 726
19. J.S. Greenberger, and M. Epperly Bone marrow-derived stem cells and radiation response Semin Radiat Oncol 19 2009 133 139
20. R. Day, M. Barshishat-Kupper, S. Mog, E. McCart, P. Prasanna, and T. Davis Genistein protects against biomarkers of delayed lung sequelae in mice surviving high dose total body irradiation J Radiat Res 49 2008 361 372
21. A.E. Para, A. Bezjak, I.W. Yeung, J. Van Dyk, and R.P. Hill Effects of genistein following fractionated lung irradiation in mice Radiother Oncol 92 2009 500 510
22. S. Banerjee, Y. Li, Z. Wang, and F. Sarkar Multi-targeted therapy of cancer by genistein Cancer Lett 269 2008 26 42
23. G.G. Hillman, Y. Wang, O. Kucuk, M. Che, D.R. Doerge, and M. Yudelev Genistein potentiates inhibition of tumor growth by radiation in a prostate cancer orthotopic model Mol Cancer Ther 3 2004 1271 1279
24. E.P. Cohen, M. Bedi, A.A. Irving, E. Jacobs, R. Tomic, and J. Klein Mitigation of late renal and pulmonary injury after hematopoietic stem cell transplantation Int J Radiat Oncol Biol Phys 83 2011 292 296
25. J.A. Schoenberger, M. Testa, A.D. Ross, W.K. Brennan, and J.A. Bannon Efficacy, safety, and quality-of-life assessment of captopril antihypertensive therapy in clinical practice Arch Intern Med 150 1990 301 306
26. J.E. Moulder, E.P. Cohen, and B.L. Fish Captopril and losartan for mitigation of renal injury caused by single-dose total-body irradiation Radiat Res 175 2011 29 36
27. L. Kma, F. Gao, B.L. Fish, J.E. Moulder, E.R. Jacobs, and M. Medhora Angiotensin converting enzyme inhibitors mitigate collagen synthesis induced by a single dose of radiation to the whole thorax J Radiat Res 53 2012 10 17
28. M. Medhora, F. Gao, E.R. Jacobs, and J.E. Moulder Radiation damage to the lung: mitigation by angiotensin-converting enzyme (ACE) inhibitors Respirology 17 2012 66 71
29. S.N. Ghosh, R. Zhang, B.L. Fish, V.A. Semenenko, X.A. Li, and J.E. Moulder Renin-angiotensin system suppression mitigates experimental radiation pneumonitis Int J Radiat Oncol Biol Phys 75 2009 1528 1536
30. C.W. McPherson Reduction of Pseudomonas aeruginosa and coliform bacteria in mouse drinking water following treatment with hydrochloric acid or chlorine Lab Anim Care 13 1963 737 744
31. G. Escribano, D. Torrado, and D. Torrado Stability study of an aqueous formulation of captopril at 1 mg/ml (Spanish) Farm Hosp 29 2005 30 36
32. M. Barshishat-Kupper, O. Mungunsukh, A.J. Tipton, E.A. McCart, R.A. Panganiban, and T.A. Davis Captopril modulates hypoxia-inducible factors and erythropoietin responses in a murine model of total body irradiation Exp Hematol 39 2011 293 304
33. B.J. Moeller, Y. Cao, C.Y. Li, and M.W. Dewhirst Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules Cancer Cell 5 2004 429 441
34. J. Mahmood, S. Jelveh, V. Calveley, A. Zaidi, S.R. Doctrow, and R.P. Hill Mitigation of radiation-induced lung injury by genistein and EUK-207 Int Radiat Biol 87 2011 889 901
35. S.J. Hosseinimehr, A. Mahmoudzadeh, and S. Akhlagpour Captopril protects mice bone marrow cells against genotoxicity induced by gamma irradiation Cell Biochem Funct 25 2007 389 394
36. Y. Kataoka, J.S. Murley, K.L. Baker, and D.J. Grdina Relationship between phosphorylated histone H2AX formation and cell survival in human microvascular endothelial cells (HMEC) as a function of ionizing radiation exposure in the presence or absence of thiol-containing drugs Radiat Res 168 2007 106 114
37. S. Charrier, A. Michaud, S. Badaoui, S. Giroux, E. Ezan, and F. Sainteny Inhibition of angiotensin I-converting enzyme induces radioprotection by preserving murine hematopoietic short-term reconstituting cells Blood 104 2004 978 985
38. P. Tamulevicius, M. Wang, and G. Iliakis Homology-directed repair is required for the development of radioresistance during S phase: interplay between double-strand break repair and checkpoint response Radiat Res 167 2007 1 11
39. D.J. Grdina, J.S. Murley, and Y. Kataoka Radioprotectants: current status and new directions Oncology 63 Suppl. 2 2002 2 10
40. K. Rodgers, S. Xiong, R. Steer, and G. DiZerega Effect of angiotensin II on hematopoietic progenitor cell proliferation Stem Cells 18 2000 287 294
41. E.T. Zambidis, T.S. Park, W. Yu, A. Tam, M. Levine, and X. Yuan Expression of angiotensin-converting enzyme (CD143) identifies and regulates primitive hemangioblasts derived from human pluripotent stem cells Blood 112 2008 3601 3614
42. J. Cole, D. Ertoy, H. Lin, R.L. Sutliff, E. Ezan, and T.T. Guyene Lack of angiotensin II-facilitated erythropoiesis causes anemia in angiotensin- converting enzyme-deficient mice J Clin Invest 106 2000 1391 1398
43. S. Freudenthaler, P. Benohr, A. Grenz, T. Selzer, T. Schmidt, and K. Morike Do alterations of endogenous angiotensin II levels regulate erythropoietin production in humans? Br J Clin Pharmacol 56 2003 378 387
44. M. Mrug, T. Stopka, B.A. Julian, J.F. Prchal, and J.T. Prchal Angiotensin II stimulates proliferation of normal early erythroid progenitors J Clin Invest 100 1997 2310 2314